KLK3 and posterior cortical atrophy: Taking that into account, in our study, PSA values between 4.1 and 4.9 μg/L consistently excluded aggressive PCa (NPV, 97.5%), therefore suggesting to place these patients under active surveillance with a biennial PSA retesting (Figure 2).